Worldwide, more than a billion people suffer from vision impairment and entirely avoidable blindness. Cataracts — and the surgery to correct them — is one of the most common surgical procedures in the world, with more than 28 million performed worldwide, every year. The problem is, even though the surgery is relatively simple, there aren’t enough surgeons, and not enough money to pay those surgeons, especially in developing countries. ForSight Robotics wants to address that issue and just raised a $55 million Series A to continue develop its surgery robots. The round comes around 18 months after its seed round.
The surgery robot platform is called Oryom, which means “daylight” in Hebrew. It leverages cutting-edge technologies (pun intended) in microsurgical robotics, computer vision and machine learning. The platform aims to automate ophthalmic surgeries that treat diseases underlying preventable blindness. With the power of robotics on its side, the company claims to be 10 times more accurate than the human hand.
Continue reading… “ForSight sees a world without cataracts with its surgery robot”
